PDS Biotechnology Corporation
NasdaqCM:PDSB
Sector
Location
Market Cap
USD 50.28 M
Share Price
USD 1.10
Avg Daily Volume
583,562
Change (1 day)
-3.51%
Change (1 year)
-68.21%
Change (YTD)
-32.52%
PDS Biotechnology Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024: USD -34.43 M
PDS Biotechnology Corporation Operating Cash Flow is USD -34.43 M for the Trailing 12 Months (TTM) ending June 30, 2024, a 9.56% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
PDS Biotechnology Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -31.43 M, a 43.37% change year over year.
-
PDS Biotechnology Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -21.92 M.
StockViz
Competitors
Mereo BioPharma Group plc
USD 1.74
MREO
+0.03
1.75%
Corvus Pharmaceuticals, Inc.
USD 4.38
CRVS
-0.14
-3.10%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|